A 58-year-old patient from the United Kingdom, diagnosed with stage IIIA EGFR-positive non-small cell lung cancer, confronted a challenging treatment landscape. National Health Service waiting times for surgery could extend for months, while private care in the UK was priced at over £60,000. After exploring various options, the patient decided to pursue medical treatment in China. The First Affiliated Hospital of Zhejiang University, a JCI-accredited facility in Hangzhou recognized for its expertise in infectious diseases and transplant programs, along with Sun Yat-sen Memorial Hospital in Guangzhou—a historic institution founded in 1835 with a robust international department—were identified as leading choices. The patient reached out to SSAnkang for support with pre-departure medical preparation. The treating physician at Cancer Hospital CAMS recommended a combination of surgery and adjuvant TKI therapy, with an estimated total cost between $22,000 and $35,000 for the full 75-day program—less than half the cost of private treatment in the UK. The decision was straightforward: proceed with treatment in China.
Pre-departure preparation began three months before the scheduled travel. The patient gathered all medical records, including pathology slides, CT scans, the EGFR mutation report, and a referral letter from the UK oncologist. SSAnkang's case manager coordinated with the hospital's international department to pre-review the records. The patient underwent a comprehensive blood workup, including liver and kidney function tests, to confirm eligibility for TKI therapy. A consultation with a Traditional Chinese Medicine specialist was arranged to support chronic disease management, costing $2,000 to $8,000 for a 14- to 30-day program—an integrative approach aimed at mitigating side effects. The patient applied for a medical visa (S visa) using a letter of invitation from the hospital. Travel insurance covering medical evacuation and potential complications was obtained. A Mandarin phrasebook focused on medical terms was downloaded. The patient also received a pre-travel checklist: pack all medications in their original bottles, bring a portable ECG monitor, and prepare digital copies of all documents. Three weeks before departure, a final telehealth call with the treating physician confirmed the treatment plan.
Upon arrival in Guangzhou, a hospital liaison greeted the patient at the airport. The first week involved baseline imaging and blood tests at Sun Yat-sen Memorial Hospital. Surgery was scheduled for day 8: a video-assisted thoracoscopic lobectomy. The procedure took four hours, and the patient was extubated in the operating room. After surgery, the patient was moved to a private room in the international ward. Adjuvant TKI therapy with osimertinib began on day 14. The patient also chose a 14-day TCM program to address fatigue and nausea, supervised by the hospital's integrative medicine unit. Blood pressure and ECG were monitored daily. The patient's daughter, who accompanied her, noted the hospital's bilingual nursing staff and the availability of Western-style meals. By day 21, surgical drains were removed, and the patient was walking independently. The treating physician reviewed the pathology report, confirming clear margins and no nodal involvement.
Recovery continued for 30 days following surgery. The patient remained in Guangzhou for the first two weeks, participating in daily physiotherapy sessions. By day 45, the patient could climb two flights of stairs without experiencing shortness of breath. The TCM program helped reduce the severity of TKI-related diarrhea. Weekly blood tests showed stable liver enzyme levels. The patient's daughter, a former nurse, managed the medication schedule using a smartphone app. The hospital's international department arranged a follow-up CT scan on day 60, which showed no residual disease. The patient transitioned to a maintenance dose of osimertinib. A final consultation with the treating physician confirmed that the patient could travel home after day 75. The patient booked a business-class seat for the 12-hour flight to London, with a letter from the hospital requesting wheelchair assistance at the airport.
At 18 months after treatment, the patient had no evidence of disease. The total cost paid to the hospital was $28,000, plus $4,000 for travel and accommodation—a fraction of the private quote in the UK. The patient continued TKI therapy under NHS supervision, with CT scans every three months. The integrative TCM program was credited by the patient for minimizing side effects. The patient's daughter wrote to SSAnkang, praising the seamless coordination and the quality of care at Sun Yat-sen Memorial Hospital. The patient remains active, walking 10,000 steps daily, and has returned to part-time work. This case highlights how thorough pre-departure medical preparation can lead to excellent outcomes in China, with world-class hospitals like The First Affiliated Hospital of Zhejiang University and Sun Yat-sen Memorial Hospital offering affordable, high-quality care. For those considering a similar journey, SSAnkang provides end-to-end support—from record review to visa assistance and follow-up care coordination.
Top comments (0)